http://www.advaxis.com
Advaxis, Inc. Company Intro
The Investor Relations website contains information about Advaxis, Inc.'s business for stockholders, potential investors, and financial analysts.
Industry
Healthcare
Advaxis, Inc. Headquaters
305 College Road East
Princeton,08540
United States
Advaxis, Inc. Share price
21 Oct 2020 01:02 GMT
$0.4600
0.0 (0.0 %)
Advaxis, Inc. Market cap
$30.485 M
WMC RANKING
2020
Advaxis, Inc. # 255
BiotechnologyLatest Advaxis, Inc. News
20 Oct 2020
Neuroblastoma Drug Market Growth & Competitive Analysis ...
Neuroblastoma Drug Market Growth & Competitive Analysis MacroGenics, Inc, Advaxis, Amgen Inc, AstraZeneca, Bristol-Myers Squibb Company.
21 Oct 2020
Prostate Specific Antigen Market Analysis, Innovation Trends ...
Competitive landscape: Advaxis, Inc., Curevac AG, Aeterna Zentaris Inc., ... Current and predicted market share as well as valuation of each company mentioned ...
21 Oct 2020
Cervical Cancer Diagnostics and Therapeutics Market 2020 – Growth Prospects with Revenue, Product Sales Volume, Opportunities, Forecast Research by 2024
Advaxis Inc. Becton, Dickinson and Company; F. Hoffmann; La Roche Ltd. Market Overview: The factors propelling the growth of the cervical cancer ...
WMC Market Score
WMC Market to Revenue Score
| Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score | |
| Advaxis, Inc. | 0.00 | 3.14 | 0 | 0 | 0 | 0 | 2.36 |
| Alexion Pharmaceuticals, Inc. | 100 | 13.15 | 100 | 19 | 0 | 0 | 98.93 |
| Vertex Pharmaceuticals Incorporated | 97.58 | 100 | 3.89 | 30 | 0 | 0 | 100 |
| 3SBio Inc. | 96.05 | 0 | 0 | 4 | 0 | 0 | 3.02 |
| Incyte Corporation | 40.27 | 14.26 | 7.06 | 100 | 0 | 0 | 90.93 |
Advaxis, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Advaxis, Inc. | $254 | $30,589 | $-30,197 | $30.485M | 255 |
| Alexion Pharmaceuticals, Inc. | $5,536,800 | $2,523,000 | $846,100 | $27.177B | 1 |
| Vertex Pharmaceuticals Incorporated | $5,402,685 | $2,634,428 | $2,080,775 | $55.881B | 2 |
| 3SBio Inc. | ¥5,318,091 | ¥3,085,221 | ¥973,717 | ¥20.867B | 3 |
| Incyte Corporation | $2,229,409 | $1,622,822 | $446,906 | $19.532B | 4 |